These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 19280541

  • 1. Impact of pantoprazole on duodeno-gastro-esophageal reflux (DGER).
    Kunsch S, Neesse A, Linhart T, Steinkamp M, Fensterer H, Adler G, Gress TM, Ellenrieder V.
    Z Gastroenterol; 2009 Mar; 47(3):277-82. PubMed ID: 19280541
    [Abstract] [Full Text] [Related]

  • 2. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?
    Tack J, Koek G, Demedts I, Sifrim D, Janssens J.
    Am J Gastroenterol; 2004 Jun; 99(6):981-8. PubMed ID: 15180713
    [Abstract] [Full Text] [Related]

  • 3. Increased Duodeno-Gastro-Esophageal Reflux (DGER) in symptomatic GERD patients with a history of cholecystectomy.
    Kunsch S, Neesse A, Huth J, Steinkamp M, Klaus J, Adler G, Gress TM, Ellenrieder V.
    Z Gastroenterol; 2009 Aug; 47(8):744-8. PubMed ID: 19662586
    [Abstract] [Full Text] [Related]

  • 4. Prospective evaluation of duodenogastroesophageal reflux in gastroesophageal reflux disease patients refractory to proton pump inhibitor therapy.
    Kunsch S, Neesse A, Linhart T, Nell C, Gress TM, Ellenrieder V.
    Digestion; 2012 Aug; 86(4):315-22. PubMed ID: 23128301
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.
    Gasiorowska A, Navarro-Rodriguez T, Wendel C, Krupinski E, Perry ZH, Koenig K, Moty B, Powers J, Fass R.
    Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829
    [Abstract] [Full Text] [Related]

  • 6. [Prevalence of a pathological DGER (duodeno-gastric-oesophageal reflux) in patients with clinical symptoms of reflux disease].
    Kunsch S, Linhart T, Fensterer H, Adler G, Gress TM, Ellenrieder V.
    Z Gastroenterol; 2008 May; 46(5):409-14. PubMed ID: 18428099
    [Abstract] [Full Text] [Related]

  • 7. Duodenogastroesophageal reflux: results of medical treatment and antireflux surgery.
    Elhak NG, Mostafa M, Salah T, Haleem M.
    Hepatogastroenterology; 2008 May; 55(81):120-6. PubMed ID: 18507090
    [Abstract] [Full Text] [Related]

  • 8. [Is duodeno-gastro-esophageal reflux just a bystander of acid reflux?].
    Fein M, Fuchs KH, Freys SM, Maroske J, Tigges H, Thiede A.
    Zentralbl Chir; 2002 Dec; 127(12):1068-72. PubMed ID: 12529822
    [Abstract] [Full Text] [Related]

  • 9. Duodenogastro-esophageal reflux in children with refractory gastro-esophageal reflux disease.
    Hoffman I, Tertychnyy A, Ectors N, De Greef T, Haesendonck N, Tack J.
    J Pediatr; 2007 Sep; 151(3):307-11. PubMed ID: 17719945
    [Abstract] [Full Text] [Related]

  • 10. Acid and bile reflux in erosive reflux disease, non-erosive reflux disease and Barrett's esophagus.
    Hak NG, Mostafa M, Salah T, El-Hemaly M, Haleem M, Abd El-Raouf A, Hamdy E.
    Hepatogastroenterology; 2008 Sep; 55(82-83):442-7. PubMed ID: 18613384
    [Abstract] [Full Text] [Related]

  • 11. Importance of duodeno-gastro-esophageal reflux in the medical outpatient practice.
    Vaezi MF, Richter JE.
    Hepatogastroenterology; 1999 Sep; 46(25):40-7. PubMed ID: 10228763
    [Abstract] [Full Text] [Related]

  • 12. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy.
    Becker V, Bajbouj M, Waller K, Schmid RM, Meining A.
    Aliment Pharmacol Ther; 2007 Nov 15; 26(10):1355-60. PubMed ID: 17900268
    [Abstract] [Full Text] [Related]

  • 13. Bile and acid reflux in long and short segment Barrett's esophagus, and in reflux disease.
    Pfaffenbach B, Hullerum J, Orth KH, Langer M, Stabenow-Lohbauer U, Lux G.
    Z Gastroenterol; 2000 Jul 15; 38(7):565-70. PubMed ID: 10965553
    [Abstract] [Full Text] [Related]

  • 14. Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients.
    Calabrese C, Liguori G, Gabusi V, Gionchetti P, Rizzello F, Straforini G, Brugnera R, Di Febo G.
    Aliment Pharmacol Ther; 2008 Jul 15; 28(2):250-5. PubMed ID: 18485128
    [Abstract] [Full Text] [Related]

  • 15. Relationship between symptom response and esophageal pH level on standard dose of esomeprazole treatment for gastroesophageal reflux disease.
    Peng S, Xiong LS, Xiao YL, Wang AJ, Lin JK, Hu PJ, Chen MH.
    Chin Med J (Engl); 2010 Aug 05; 123(15):2012-7. PubMed ID: 20819534
    [Abstract] [Full Text] [Related]

  • 16. Characteristics and clinical relevance of proximal esophageal pH monitoring.
    Cool M, Poelmans J, Feenstra L, Tack J.
    Am J Gastroenterol; 2004 Dec 05; 99(12):2317-23. PubMed ID: 15571576
    [Abstract] [Full Text] [Related]

  • 17. Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily.
    Haag S, Holtmann G.
    Clin Ther; 2010 Apr 05; 32(4):678-90. PubMed ID: 20435237
    [Abstract] [Full Text] [Related]

  • 18. Biliary reflux and non-acid reflux are two distinct phenomena: a comparison between 24-hour multichannel intraesophageal impedance and bilirubin monitoring.
    Pace F, Sangaletti O, Pallotta S, Molteni P, Porro GB.
    Scand J Gastroenterol; 2007 Sep 05; 42(9):1031-9. PubMed ID: 17710667
    [Abstract] [Full Text] [Related]

  • 19. Clinically distinct characteristics in patients younger than 40 years old with non-cardiac chest pain.
    Ko SY, Kim SI, Kim JH, Lee JH, Lee KJ, Hong SN, Lee SY, Sung IK, Park HS, Shim CS.
    J Gastroenterol Hepatol; 2012 Sep 05; 27(9):1484-9. PubMed ID: 22554344
    [Abstract] [Full Text] [Related]

  • 20. Randomised clinical trial: daily pantoprazole magnesium 40 mg vs. esomeprazole 40 mg for gastro-oesophageal reflux disease, assessed by endoscopy and symptoms.
    Moraes-Filho JP, Pedroso M, Quigley EM, PAMES Study Group.
    Aliment Pharmacol Ther; 2014 Jan 05; 39(1):47-56. PubMed ID: 24299323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.